TRIDENT LIFELINE
Back to All Ratios
|
TRIDENT LIFELINE Last 5 Year Net Sales Growth History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | |
---|---|---|---|
Net Sales Growth(%) | 40.82 | 45.59 | - |
What is the latest Net Sales Growth ratio of TRIDENT LIFELINE ?
Year | Net Sales Growth |
---|---|
Mar2024 | 40.82 |
Mar2023 | 45.59 |
Mar2022 | - |
How is Net Sales Growth of TRIDENT LIFELINE Trending?
Years | Net Sales Growth | % Change | |
---|---|---|---|
Mar2024 | 40.82 | -10.46 | |
Mar2023 | 45.59 | 0 | |
Mar2022 | 0 | - |
Other Financial Ratios of TRIDENT LIFELINE
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Net Sales Growth ratio of peers of TRIDENT LIFELINE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TRIDENT LIFELINE | ₹344.6 Cr | 0.9% | 10% | 48.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹375,388.0 Cr | -5.6% | -9.9% | -12.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,513.0 Cr | -2.5% | -8.4% | 21.7% | Stock Analytics | |
CIPLA | ₹126,733.0 Cr | -0.8% | 1.8% | -1.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,292.0 Cr | -2.4% | -4% | 4.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,935.0 Cr | -0.3% | -0.9% | -9.7% | Stock Analytics |
TRIDENT LIFELINE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TRIDENT LIFELINE | 0.9% |
10% |
48.7% |
SENSEX | -1.8% |
-1.6% |
-2% |
You may also like the below Video Courses